Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Sarcoma 5Sarcoma, Kaposi 4Unspecified Adult Solid Tumor, Protocol Specific 3Skin Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Prostatic Neoplasms 2Head and Neck Neoplasms 2HIV Infections 2Colonic Neoplasms 2AIDS-related Kaposi sarcoma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solitary Fibrous Tumor, Pleural 1Salivary Gland Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms, Unknown Primary 1Neoplasms, Plasma Cell 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Meningioma 1Melanoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1

Interventions

Carboplatin 8Paclitaxel 7Gemcitabine 7Irinotecan 6Radiotherapy 4Oxaliplatin 4Capecitabine 4Leucovorin 3Fluorouracil 3Filgrastim 3Erlotinib Hydrochloride 3Cisplatin 3Bevacizumab 3etoposide phosphate 2Trastuzumab 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Etoposide 2Amifostine 2Albumin-Bound Paclitaxel 2tipifarnib 1tegafur-gimeracil-oteracil 1sintilimab 1pertuzumab 1pemigatinib 1pembrolizumab 1olaparib 1ivosidenib 1ipatasertib 1erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Unknown Primary × Semaxinib × Clear all
NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

National Cancer Institute (NCI)

Phase 2 Completed
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡